Följ
Robert W. Dubois, MD, PhD
Robert W. Dubois, MD, PhD
National Pharmaceutical Council
Verifierad e-postadress på npcnow.org
Titel
Citeras av
Citeras av
År
Hospital Inpatient Mortality
RW Dubois, WH Rogers, JH Moxley, D Draper, RH Brook
RAND Corporation, 1991
469*1991
Best Practices: Improving Patient Outcomes and Costs in an ACO Through Comprehensive Medication Therapy Management
A Brummel, A Lustig, K Westrich, MA Evans, GS Plank, J Penso, ...
J Manag Care Pharm 20 (12), 1152-58, 2014
892014
Surveillance after polypectomy and after resection of colorectal cancer
C Arditi, JJ Gonvers, B Burnand, G Minoli, D Oertli, F Lacaine, RW Dubois, ...
Endoscopy 41 (3), 209-217, 2009
772009
Cost-effectiveness thresholds in the USA: are they coming? Are they already here?
RW Dubois
Journal of comparative effectiveness research 5 (1), 9-12, 2016
732016
Private sector risk-sharing agreements in the United States: trends, barriers, and prospects.
LP Garrison, JJ Carlson, PS Bajaj, A Towse, PJ Neumann, SD Sullivan, ...
The American journal of managed care 21 (9), 632-640, 2015
712015
Appropriateness studies.
RW Dubois
The New England journal of medicine 330 (6), 433; author reply 433-4, 1994
19*1994
Are ACOs ready to be accountable for medication use
RW Dubois, M Feldman, A Lustig, G Kotzbauer, J Penso, SD Pope, ...
J Manag Care Pharm 20 (1), 17-21, 2014
142014
Real-world impact of comparative effectiveness research findings on clinical practice.
TB Gibson, ED Ehrlich, J Graff, R Dubois, AM Farr, M Chernew, ...
The American journal of managed care 20 (6), e208-20, 2013
14*2013
Best Practices: An Electronic Drug Alert Program to Improve Safety in an Accountable Care Environment
S Griesbach, A Lustig, L Malsin, B Carley, KD Westrich, RW Dubois
Journal of managed care & specialty pharmacy 21 (4), 330-336, 2015
122015
When is evidence sufficient for decision-making? A framework for understanding the pace of evidence adoption
RW Dubois, M Lauer, E Perfetto
Journal of comparative effectiveness research 2 (4), 383-391, 2013
122013
Transparency in Evidence Evaluation And Formulary Decision-Making: From Conceptual Development to Real-World Implementation
BB Dean, KJ Ko, JS Graff, AR Localio, R Wade, RW Dubois
Pharmacy and Therapeutics 38 (8), 465, 2013
102013
From Conceptual Development to Real-World Implementation
BB Dean, RW Dubois
10*
The value of specialty pharmaceuticals-a systematic review.
M Zalesak, JS Greenbaum, JT Cohen, F Kokkotos, A Lustig, PJ Neumann, ...
The American journal of managed care 20 (6), 461-472, 2014
82014
From methods to policy: Enthusiasm for rapid-learning health systems exceeds the current standards for conducting it.
NE McElwee, RW Dubois
Journal of comparative effectiveness research 2 (5), 425, 2013
82013
Does type of bolus insulin matter in the hospital? Retrospective cohort analysis of outcomes between patients receiving analogue versus human insulin
KJ Ko, V Tomor, BH Nathanson, JR Bouchard, M Aagren, RW Dubois
Clinical therapeutics 32 (11), 1954-1966, 2010
82010
Adverse effects and reasons for switch reported by patients on antihypertensive medications
K Chen, D Glass, CF Chiou, C Plauschinat, F Frech, A Harper, R Dubois
American Journal of Hypertension 17 (5), S102, 2004
82004
The development of indications for the preoperative use of recombinant erythropoietin
RW Dubois, D Lim, P Hebert, M Sherwood, GH Growe, JF Hardy, RE Park, ...
Canadian journal of surgery 41 (5), 351, 1998
81998
Looking at CER from the pharmaceutical industry perspective
RW Dubois
Journal of Managed Care Pharmacy 18 (4), S9, 2012
72012
Solutions for filling gaps in accountable care measure sets.
T Valuck, D Dugan, RW Dubois, K Westrich, J Penso, M McClellan
The American journal of managed care 21 (10), 723-728, 2015
52015
Atypical nighttime symptoms of GERD among individuals with nighttime versus daytime GERD
RW Dubois, R Fass, LF Johnson, D Aquilar, R Lynn, A Singh, M Tedeschi
Gastroenterology 128 (4), A288-A288, 2005
52005
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20